Search research articles
Contact Us
Filters
Showing results (111-120 of 246) with videos related to
Page
of 25
Sort By:
American Journal of Hypertension
|
September 1, 1996
Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade
U L Hulthén, Z Cao, J R Rumble, et al.
The American Journal of Medicine
|
August 1, 1988
Effect of early menopause on bone mass in normal women and patients with osteoporosis
E Seeman, M E Cooper, J L Hopper, et al.
Diabetes Care
|
September 1, 1987
Long-term use of intranasal insulin in insulin-dependent diabetic patients
A G Frauman, M E Cooper, B J Parsons, et al.
Diabetologia
|
August 18, 2001
Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension
F Bonnet, M E Cooper, H Kawachi, et al.
Genetic Epidemiology
|
January 17, 2002
Quantitative trait linkage analysis of the liability underlying a common oligogenic disease
B S Maher, M M Vanyukov, M E Cooper, et al.
Diabetologia
|
April 11, 2003
ACE inhibition salvages the visual loss caused by diabetes
B V Bui, J A Armitage, M Tolcos, et al.
Journal of Diabetes and Its Complications
|
October 1, 1995
Diabetic vascular hypertrophy and albuminuria: effect of angiotensin converting enzyme inhibition
T J Allen, U L Hulthen, J R Rumble, et al.
Kidney International
|
July 28, 2001
Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats
Z Cao, L M Burrell, I Tikkanen, et al.
Diabetes Research (Edinburgh, Scotland)
|
January 1, 1994
Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat
L A Bach, M E Cooper, D Vranes, et al.
Diabetologia
|
June 16, 2000
The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation
M E Cooper, V Thallas, J Forbes, et al.
Page
of 25
Search research articles
Search
Showing results (111-120 of 246) with videos related to
Sort By:
Page
of 25
American Journal of Hypertension
|
September 1, 1996
Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade
U L Hulthén, Z Cao, J R Rumble, et al.
The American Journal of Medicine
|
August 1, 1988
Effect of early menopause on bone mass in normal women and patients with osteoporosis
E Seeman, M E Cooper, J L Hopper, et al.
Diabetes Care
|
September 1, 1987
Long-term use of intranasal insulin in insulin-dependent diabetic patients
A G Frauman, M E Cooper, B J Parsons, et al.
Diabetologia
|
August 18, 2001
Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension
F Bonnet, M E Cooper, H Kawachi, et al.
Genetic Epidemiology
|
January 17, 2002
Quantitative trait linkage analysis of the liability underlying a common oligogenic disease
B S Maher, M M Vanyukov, M E Cooper, et al.
Diabetologia
|
April 11, 2003
ACE inhibition salvages the visual loss caused by diabetes
B V Bui, J A Armitage, M Tolcos, et al.
Journal of Diabetes and Its Complications
|
October 1, 1995
Diabetic vascular hypertrophy and albuminuria: effect of angiotensin converting enzyme inhibition
T J Allen, U L Hulthen, J R Rumble, et al.
Kidney International
|
July 28, 2001
Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats
Z Cao, L M Burrell, I Tikkanen, et al.
Diabetes Research (Edinburgh, Scotland)
|
January 1, 1994
Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat
L A Bach, M E Cooper, D Vranes, et al.
Diabetologia
|
June 16, 2000
The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation
M E Cooper, V Thallas, J Forbes, et al.
Page
of 25